1.A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
Hee Jin PARK ; Sung Jin KIM ; Rok SONG ; Jing CHEN ; Joon Hyung KIM ; Raghavendra DEVADIGA ; Hee Cheol KANG
Journal of Korean Medical Science 2019;34(12):e105-
BACKGROUND: Incidence of whooping cough is increasing in Korea. Since 2011, occurrence among adolescents and adults has risen putting vulnerable neonates at risk. National immunization guidelines now include Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccination during pregnancy and as a cocooning strategy (i.e., vaccinating adults and adolescents in contact with neonates). This study assessed post-marketing Tdap (Boostrix®, GSK, Belgium) vaccine safety in subjects ≥ 10 years. METHODS: This open, non-comparative multi-center study was conducted over six years at 10 hospitals in Korea. Subjects received Tdap in normal clinical practice according to local prescribing information. All adverse events (AEs) were recorded, classified as expected or unexpected, and severity and relationship to Tdap were assessed. RESULTS: The analysis included 672 Korean subjects (mean age, 44 years; range, 11–81), 451 were women and 211 were pregnant. Ninety subjects experienced 124 AEs (incidence 13.39%) of which six were serious AEs (SAEs) assessed as not related to vaccination, and 51 were non-SAEs related to vaccination (mostly administration site reactions). Overall 65/124 AEs were unexpected; the most common were 14 constipation, 5 dyspepsia, 4 common cold and 4 premature labor cases. One case of common cold was assessed as possibly related to vaccination. Pregnancy outcome was ‘live infant, no apparent congenital anomaly’ in 195 subjects (92.42%) or ‘lost to follow-up’ in 16 subjects. CONCLUSION: Tdap administration to Korean subjects ≥ 10 years, including pregnant women, for the prevention of diphtheria, tetanus and pertussis was shown to have a well-tolerated safety profile. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01929291
Adolescent
;
Adult
;
Common Cold
;
Constipation
;
Diphtheria Toxoid
;
Diphtheria
;
Dyspepsia
;
Female
;
Humans
;
Immunization
;
Incidence
;
Infant
;
Infant, Newborn
;
Korea
;
Obstetric Labor, Premature
;
Pregnancy
;
Pregnancy Outcome
;
Pregnant Women
;
Prospective Studies
;
Tetanus Toxoid
;
Tetanus
;
Vaccination
;
Whooping Cough
2.Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.
Jung Ran CHOI ; Jang Young KIM ; Il Hwan PARK ; Ji Hye HUH ; Ki Woo KIM ; Seung Kuy CHA ; Kyu Sang PARK ; Joon Hyung SOHN ; Jong Taek PARK ; Sang Baek KOH
Yonsei Medical Journal 2018;59(2):287-293
PURPOSE: Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a potential marker for the early identification of metabolic syndrome (MetS), we investigated the association between serum FGF21 level and the development of MetS in a population-based prospective study. MATERIALS AND METHODS: We conducted a prospective study of 221 randomly sampled adults without MetS from a general population-based cohort study who were examined from 2005–2008 (baseline) and from 2008–2011 (follow-up). Baseline serum FGF21 levels were analyzed using enzyme-linked immunosorbent assay. RESULTS: During the average 2.8-year follow-up period, 82 participants (36.6%) developed new-onset MetS. Serum FGF21 levels were significantly higher in patients with new-onset MetS than in those without MetS (209.56±226.80 vs. 110.09±81.10, p < 0.01). In multivariate adjusted models, the odds for MetS development were greater in patients with serum FGF21 levels in the highest quartile, compared to those in the lowest quartile (3.84, 95% confidence interval: 1.59–9.28). CONCLUSION: Serum FGF21 level was an independent predictor for new-onset MetS in a population-based prospective study.
Biomarkers/blood
;
Female
;
Fibroblast Growth Factors/*blood
;
Humans
;
Male
;
Metabolic Syndrome/*blood
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prospective Studies
3.Introduction of an Educational Accreditation System for Abdominal Ultrasonography.
Jae Myung CHA ; Dong Ki LEE ; Hyung Joon YIM ; Jin Mo YANG ; Seung Ok LEE ; Sung Koo LEE
The Korean Journal of Gastroenterology 2018;71(6):303-307
Abdominal ultrasonography uses the transmission and reflection of ultrasound waves to observe the internal organs through the abdominal wall and can visualize various abdominal anatomical structures. Abdominal ultrasound examinations are performed by gastroenterologists or other specialists in internal medicine and radiologists trained for this procedure. Thus far, abdominal ultrasonography has not been included in the standard education of gastroenterologists in Korea. On the other hand, abdominal ultrasonography is being used increasingly, making it necessary to establish a training program in Korea. Abdominal ultrasonography was established as an essential part of education for the resident training program in 2017. In addition, an educational accreditation system for the trainers of ultrasonography in the field of internal medicine, including gastroenterology, was developed in 2018. This article describes the development process of the educational accreditation system for trainers of ultrasonography.
Abdomen
;
Abdominal Wall
;
Accreditation*
;
Education
;
Gastroenterology
;
Hand
;
Internal Medicine
;
Korea
;
Specialization
;
Ultrasonic Waves
;
Ultrasonography*
4.Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein
Hyun Joo KIM ; Gil Sun CHA ; Hyung Joon KIM ; Eun Young KWON ; Ju Youn LEE ; Jeomil CHOI ; Ji Young JOO
Journal of Periodontal & Implant Science 2018;48(1):60-68
PURPOSE: The aim of this study was to evaluate the ability of Porphyromonas gingivalis (P. gingivalis) to induce oxidation of high-density lipoprotein (HDL) and to determine whether the oxidized HDL induced by P. gingivalis exhibited altered antiatherogenic function or became proatherogenic. METHODS: P. gingivalis and THP-1 monocytes were cultured, and the extent of HDL oxidation induced by P. gingivalis was evaluated by a thiobarbituric acid-reactive substances (TBARS) assay. To evaluate the altered antiatherogenic and proatherogenic properties of P. gingivalis-treated HDL, lipid oxidation was quantified by the TBARS assay, and tumor necrosis factor alpha (TNF-α) levels and the gelatinolytic activity of matrix metalloproteinase (MMP)-9 were also measured. After incubating macrophages with HDL and P. gingivalis, Oil Red O staining was performed to examine foam cells. RESULTS: P. gingivalis induced HDL oxidation. The HDL treated by P. gingivalis did not reduce lipid oxidation and may have enhanced the formation of MMP-9 and TNF-α. P. gingivalis-treated macrophages exhibited more lipid aggregates than untreated macrophages. CONCLUSIONS: P. gingivalis induced HDL oxidation, impairing the atheroprotective function of HDL and making it proatherogenic by eliciting a proinflammatory response through its interaction with monocytes/macrophages.
Atherosclerosis
;
Cardiovascular Diseases
;
Cholesterol
;
Foam Cells
;
Lipoproteins
;
Macrophages
;
Monocytes
;
Periodontitis
;
Porphyromonas gingivalis
;
Porphyromonas
;
Thiobarbituric Acid Reactive Substances
;
Tumor Necrosis Factor-alpha
5.Design of Korean Noninvasive Risk Evaluation Study for Sudden Cardiac Death from Infarction or Heart Failure: Myocardial infarction study of K-REDEFINE registry.
Seung Jung PARK ; Gyo Seung HWANG ; Gi Byoung NAM ; Hyung Wook PARK ; Joong Wha CHUNG ; Seung Yong SHIN ; Sang Min KIM ; Jun Hyung KIM ; Young Soo LEE ; Yae Min PARK ; Jong Youn KIM ; Dae Hyeok KIM ; Dae Kyeong KIM ; June NAMGUNG ; Dae Hee SHIN ; Joon Hyouk CHOI ; Hyoung Seob PARK ; Jong Il CHOI ; Jin Seok KIM ; Tae Joon CHA ; Sang Weon PARK ; Jae Sun UHM ; Nam Ho KIM ; Minsoo AHN ; Dong Gu SHIN ; Nuri JANG ; Meemo PARK ; June Soo KIM
International Journal of Arrhythmia 2017;18(1):6-15
BACKGROUND AND OBJECTIVES: Despite significant advances in the treatment of acute myocardial infarction (MI), the prevention of sudden cardiac death (SCD), the most common mode of death in patients with MI, remains challenging. Furthermore, previous Korean MI registries did not address the issue of post-MI SCD. Additional risk stratifiers of post-MI SCD are still required to compensate for the limitation of using left ventricular ejection fraction to predict lethal arrhythmic events. SUBJECTS AND METHODS: We designed the first Korean prospective nationwide multicenter registry primarily focused on SCD; the Korean noninvasive Risk Evaluation study for sudden cardiac DEath From INfarction or heart failurE (K-REDEFINE). The registry consists of 2 groups of patients presenting with (1) acute MI or (2) acute heart failure (HF) at 25 tertiary referral cardiovascular centers. The primary endpoint of the MI group study of K-REDEFINE registry is the incidence and risk factors of post-MI SCD. In particular, the association between the risk of SCD and non-invasive Holter-based electrocardiogram (ECG) variables will be evaluated, such as T-wave alternans (marker of repolarization heterogeneity) and heart rate turbulence/variability (a marker of autonomic function). Other secondary study outcomes include atrioventricular arrhythmias, HF-related admission, repeated myocardial ischemic events, stroke, and overall deaths. CONCLUSION AND PERSPECTIVE: The K-REDEFINE registry will provide new prospects for the better management of MI patients with high risk of SCD by clarifying the burden and predictors of SCD and the clinical utility of various non-invasive ambulatory ECG-based variables in risk stratification for SCD in this patient population.
Arrhythmias, Cardiac
;
Death, Sudden, Cardiac*
;
Electrocardiography
;
Heart Failure*
;
Heart Rate
;
Heart*
;
Humans
;
Incidence
;
Infarction*
;
Myocardial Infarction*
;
Prospective Studies
;
Referral and Consultation
;
Registries
;
Risk Factors
;
Stroke
;
Stroke Volume
6.Comparison of changes in the transverse dental axis between patients with skeletal Class III malocclusion and facial asymmetry treated by orthognathic surgery with and without presurgical orthodontic treatment.
Han Sol SONG ; Sung Hwan CHOI ; Jung Yul CHA ; Kee Joon LEE ; Hyung Seog YU
The Korean Journal of Orthodontics 2017;47(4):256-267
OBJECTIVE: To evaluate transverse skeletal and dental changes, including those in the buccolingual dental axis, between patients with skeletal Class III malocclusion and facial asymmetry after bilateral intraoral vertical ramus osteotomy with and without presurgical orthodontic treatment. METHODS: This retrospective study included 29 patients with skeletal Class III malocclusion and facial asymmetry including menton deviation > 4 mm from the midsagittal plane. To evaluate changes in transverse skeletal and dental variables (i.e., buccolingual inclination of the upper and lower canines and first molars), the data for 16 patients who underwent conventional orthognathic surgery (CS) were compared with those for 13 patients who underwent preorthodontic orthognathic surgery (POGS), using three-dimensional computed tomography at initial examination, 1 month before surgery, and at 7 days and 1 year after surgery. RESULTS: The 1-year postsurgical examination revealed no significant changes in the postoperative transverse dental axis in the CS group. In the POGS group, the upper first molar inclined lingually on both sides (deviated side, −1.8°± 2.8°, p = 0.044; nondeviated side, −3.7°± 3.3°, p = 0.001) and the lower canine inclined lingually on the nondeviated side (4.0°± 5.4°, p = 0.022) during postsurgical orthodontic treatment. There were no significant differences in the skeletal and dental variables between the two groups at 1 year after surgery. CONCLUSIONS: POGS may be a clinically acceptable alternative to CS as a treatment to achieve stable transverse axes of the dentition in both arches in patients with skeletal Class III malocclusion and facial asymmetry.
Dentition
;
Facial Asymmetry*
;
Humans
;
Malocclusion*
;
Molar
;
Orthognathic Surgery*
;
Osteotomy
;
Retrospective Studies
7.Adverse Cardiovascular Events after a Venomous Snakebite in Korea.
Oh Hyun KIM ; Joon Woo LEE ; Hyung Il KIM ; Kyoungchul CHA ; Hyun KIM ; Kang Hyun LEE ; Sung Oh HWANG ; Yong Sung CHA
Yonsei Medical Journal 2016;57(2):512-517
PURPOSE: Although cardiac involvement is an infrequently recognized manifestation of venomous snakebites, little is known of the adverse cardiovascular events (ACVEs) arising as a result of snakebite in Korea. Accordingly, we studied the prevalence of ACVEs associated with venomous snakebites in Korea and compared the clinical features of patients with and without ACVEs. MATERIALS AND METHODS: A retrospective review was conducted on 65 consecutive venomous snakebite cases diagnosed and treated at the emergency department of Wonju Severance Christian Hospital between May 2011 and October 2014. ACVEs were defined as the occurrence of at least one of the following: 1) myocardial injury, 2) shock, 3) ventricular dysrhythmia, or 4) cardiac arrest. RESULTS: Nine (13.8%) of the 65 patients had ACVEs; myocardial injury (9 patients, 13.8%) included high sensitivity troponin I (hs-TnI) elevation (7 patients, 10.8%) or electrocardiogram (ECG) determined ischemic change (2 patients, 3.1%), and shock (2 patient, 3.1%). Neither ventricular dysrhythmia nor cardiac arrest was observed. The median of elevated hs-TnI levels observed in the present study were 0.063 ng/mL (maximum: 3.000 ng/mL) and there was no mortality in the ACVEs group. Underlying cardiac diseases were more common in the ACVEs group than in the non-ACVEs group (p=0.017). Regarding complications during hospitalization, 3 patients (5.4%) in the non-ACVEs group and 3 patients (33.3%) in the ACVEs group developed bleeding (p=0.031). CONCLUSION: Significant proportion of the patients with venomous snakebite is associated with occurrence of ACVEs. Patients with ACVEs had more underlying cardiac disease and bleeding complication.
Aged
;
Arrhythmias, Cardiac/epidemiology/*etiology
;
Cardiovascular Diseases/epidemiology
;
Electrocardiography
;
Emergency Service, Hospital
;
Female
;
Heart Arrest/epidemiology/*etiology
;
Hospitalization
;
Humans
;
Male
;
Middle Aged
;
Prevalence
;
Republic of Korea
;
Retrospective Studies
;
Snake Bites/*complications/diagnosis/epidemiology
;
Troponin I/blood
8.Design of Korean Noninvasive Risk Evaluation Study for Sudden Cardiac Death from Infarction or Heart Failure: Heart failure study of K-REDEFINE registry.
Seung Jung PARK ; Gyo Seung HWANG ; Gi Byoung NAM ; Hyung Wook PARK ; Joong Wha CHUNG ; Seung Yong SHIN ; Sang Min KIM ; Jun Hyung KIM ; Young Soo LEE ; Yae Min PARK ; Jong Youn KIM ; Dae Hyeok KIM ; Dae kyeong KIM ; June NAMGUNG ; Dae Hee SHIN ; Joon Hyouk CHOI ; Hyoung Seob PARK ; Jong Il CHOI ; Jin Seok KIM ; Tae Joon CHA ; Sang Weon PARK ; Jae Sun UHM ; Nam Ho KIM ; Minsoo AHN ; Dong Gu SHIN ; Nuri JANG ; Meemo PARK ; June Soo KIM
International Journal of Arrhythmia 2016;17(4):181-189
BACKGROUND AND OBJECTIVES: Sudden cardiac death (SCD) is one of the most common causes of death in patients with heart failure (HF). However, there are no available data on SCD in previous Korean HF registries. Additionally, although widely used, the utility of left ventricular (LV) ejection fraction (EF) in risk stratification for SCD is limited. SUBJECTS AND METHODS: The Korean non-invasive Risk Evaluation study for sudden cardiac DEath From INfarction or heart failurE (KREDEFINE) is the first Korean prospective, nationwide multicenter registry, primarily focused on SCD. The registry consists of 2 groups of patients presenting with (1) acute HF or (2) acute myocardial infarction (MI) at 25 tertiary referral cardiovascular centers. Using the HF-group data of the K-REDEFINE registry, the incidence and risk factors of SCD in patients with HF will be assessed. In particular, the efficacy of Holter-based ECG variables, such as T-wave alternans (marker of repolarization heterogeneity) and heart rate turbulence/ variability (maker of autonomic function), in risk stratification for SCD will be evaluated. Other cardiovascular outcomes will also be analyzed, including atrioventricular arrhythmias, HF-related admission, stroke, and overall deaths. CONCLUSION AND PERSPECTIVE: The K-REDEFINE registry will pave the way for better management of patients with HF at high risk of SCD by elucidating the burden and risk factors of SCD and the clinical utility of various non-invasive ambulatory ECG-based parameters in risk stratification for SCD in this patient population.
Arrhythmias, Cardiac
;
Cause of Death
;
Death, Sudden, Cardiac*
;
Electrocardiography
;
Heart Failure*
;
Heart Rate
;
Heart*
;
Humans
;
Incidence
;
Infarction*
;
Myocardial Infarction
;
Prospective Studies
;
Referral and Consultation
;
Registries
;
Risk Factors
;
Stroke
9.The usefulness of serum delta neutrophil index for differentiating bacterial and viral meningitis in the emergency department.
Joon Woo LEE ; Chan Ik PARK ; Hyung Il KIM ; Oh Hyun KIM ; Kyoung Chul CHA ; Hyun KIM ; Kang Hyun LEE ; Sung Oh HWANG ; Yong Sung CHA
Clinical and Experimental Emergency Medicine 2016;3(2):95-99
OBJECTIVE: When managing patients with acute meningitis in an emergency department (ED), early diagnosis of the type of infection (bacterial or viral) considerably affects the clinical course and treatment because of the high mortality and morbidity associated with bacterial meningitis (BM). The serum delta neutrophil index (DNI), a new inflammatory marker, reflects the fraction of circulating immature granulocytes and is elevated in cases of bacterial infection. The objective of this study was to evaluate whether serum DNI can be used to differentiate between BM and viral meningitis (VM) in the ED. METHODS: This retrospective, observational study included 104 consecutive patients (aged >18 years) diagnosed with acute meningitis from January 2012 to November 2014 in a regional emergency center. White blood cell and neutrophil counts, C-reactive protein level, and DNI were evaluated regarding their usefulness for differentiating BM and VM. RESULTS: Serum DNI was not significantly higher in the BM group (n=12) than in the VM group (n=92) (0 [interquartile range, 0% to 2.73%] vs. 0 [interquartile range, 0 to 0%], P=0.057). However, the white blood cell count and C-reactive protein level were statistically higher in the BM group (P=0.034 and P=0.026, respectively). Serum DNI was not found to be a statistically useful differential diagnostic parameter (area under the curve, 0.628; 95% confidence interval, 0.438 to 0.818). CONCLUSION: Currently, there is no evidence that the serum DNI aids in differentiating acute BM from acute VM in the ED.
Bacterial Infections
;
Biomarkers
;
C-Reactive Protein
;
Early Diagnosis
;
Emergencies*
;
Emergency Service, Hospital*
;
Granulocytes
;
Humans
;
Leukocyte Count
;
Leukocytes
;
Meningitis
;
Meningitis, Bacterial
;
Meningitis, Viral*
;
Mortality
;
Neutrophils*
;
Observational Study
;
Retrospective Studies
10.The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society.
Byung Chun JUNG ; Nam Ho KIM ; Gi Byung NAM ; Hyung Wook PARK ; Young Keun ON ; Young Soo LEE ; Hong Euy LIM ; Boyoung JOUNG ; Tae Joon CHA ; Gyo Seung HWANG ; Seil OH ; June Soo KIM
Korean Circulation Journal 2015;45(1):9-19
In patients with nonvalvular atrial fibrillation (AF), the risk of stroke varies considerably according to individual clinical status. The CHA2DS2-VASc score is better than the CHADS2 score for identifying truly lower risk patients with AF. With the advent of novel oral anticoagulants (NOACs), the strategy for antithrombotic therapy has undergone significant changes due to its superior efficacy, safety and convenience compared with warfarin. Furthermore, new aspects of antithrombotic therapy and risk assessment of stroke have been revealed: the efficacy of stroke prevention with aspirin is weak, while the risk of major bleeding is not significantly different from that of oral anticoagulant (OAC) therapy, especially in the elderly. Reflecting these pivotal aspects, previous guidelines have been updated in recent years by overseas societies and associations. The Korean Heart Rhythm Society has summarized the new evidence and updated recommendations for stroke prevention of patients with nonvalvular AF. First of all, antithrombotic therapy must be considered carefully and incorporate the clinical characteristics and circumstances of each individual patient, especially with regards to balancing the benefits of stroke prevention with the risk of bleeding, recommending the CHA2DS2-VASc score rather than the CHADS2 score for assessing the risk of stroke, and employing the HAS-BLED score to validate bleeding risk. In patients with truly low risk (lone AF, CHA2DS2-VASc score of 0), no antithrombotic therapy is recommended, whereas OAC therapy, including warfarin (international normalized ratio 2-3) or NOACs, is recommended for patients with a CHA2DS2-VASc score > or =2 unless contraindicated. In patients with a CHA2DS2-VASc score of 1, OAC therapy should be preferentially considered, but depending on bleeding risk or patient preferences, antiplatelet therapy or no therapy could be permitted.
Aged
;
Anticoagulants
;
Aspirin
;
Atrial Fibrillation*
;
Heart*
;
Hemorrhage
;
Humans
;
Patient Preference
;
Risk Assessment
;
Stroke
;
Warfarin

Result Analysis
Print
Save
E-mail